Drugmakers Ordered to Pay Nearly $30M to Breast Cancer Victim
Wyeth and Pfizer Inc. must pay nearly $30 million to a woman who claimed her breast cancer was linked to the hormone replacement drugs they made, an Arkansas jury said.
Federal jurors in Little Rock concluded that Arkansas resident Donna Scroggins was entitled to $2.75 million in compensatory damages and $27.1 million in punitive damages, Bloomberg News reports.
Scroggins was diagnosed with breast cancer after she was prescribed the hormone replacement drugs Premarin, Prempro and Provera for treatment of menopause symptoms such as hot flashes, night sweats and mood swings.
In 2004, she sued the manufacturers of Premarin, Prempro and Prover, Wyeth and Pfizer’s Pharmacia & Upjohn, claiming that the drugs caused her breast cancer.
The jury agreed. Not only did jurors find that the drugs caused Scroggin’s cancer, they also concluded that the manufacturers acted with “reckless disregard” when it came to the health risks posed by the drugs. Wyeth was ordered to pay about $19.4 million in punitive damages. Pfizer was ordered to pay about $7.8 million in punitive damages.
If you or a loved one suffered complications after taking hormone replacement drugs contact Carey & Danis. We can help. Carey & Danis is a national law firm that represents individuals injured by America's largest corporations.
For more information, fill out our online contact form or call Carey & Danis toll-free at 800-721-2519.
